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CASE REPORT  
 
Immune Reconstitution Inflammatory Syndrome and Shingles 
Associated with a Combined Paralysis of Three Oculomotor Nerves: 









BACKGROUND: In countries with high prevalence of HIV/AIDS infection, particularly in black Africa, 
shingles is one of the main opportunistic infections during immunosuppression due to AIDS in young 
patients. If immunological weakness is important, usually when the CD4 cell count is less than 100 
cells/mm
3
, the risk of inflammatory reactions in the first three months after initiating of antiretroviral 
treatment (ART) is very high. This inflammatory reaction is called immune reconstitution inflammatory 
syndrome (IRIS). This observation reports the first documented case of IRIS with V1 shingles in a young 
HIV patient at University Hospital of Brazzaville.  
CASE DETAILS: A 40 years old patient was seen for a pain of the right side of the face and a complete 
immobility of the eyeball. The diagnosis of V1 shingles with a pan uveitis, and a paralysis of III, IV and 
VI nerves was made. The patiants HIV status was positive and CD4 cell count was 150 cells/mm
3
. After 
two months of evolution under ART with a CD4 count of 850 cells /mm
3
, the symptomatology was quickly 
complicated by significant inflammation causing a phtisis bulbi. 
CONCLUSION: CD4 cells count is an important indicator in the HIV/AIDS therapy. In some major 
forms of IRIS, momentary pause of anti retroviral treatment is sometimes necessary. 
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INTRODUCTION 
   
Infection with varicella zoster virus (VZV), which 
is a member of the herpes virus family, is 
relatively common. In general, in childhood VZV 
causes chickenpox, and in adults it recurs to cause 
shingles. After the signs and symptoms of 
chickenpox resolve, VZV goes into a state of 
latent infection inside nerve cells (1). It is 
generally held in the check by the immune system. 
However, as the immune system weakens with 
age, VZV can become reactivated, resulting in 
shingles. Shingles is most commonly seen in 
people over the age of 50. However, there are 
cases when the immune system becomes 
weakened, such as HIV/AIDS context that can 
allow the reactivation of VZV leading to shingles 
even in younger patient (1, 2). If immunological 
weakness is important, usually when the CD4 cell 
count is less than 100 cells/mm
3
, the risk of 
inflammatory reactions in the first three months 
after initiating antiretroviral treatment (ART) is 
very high. This inflammatory reaction is called 
IRIS (3-5). We report the first documented case of 
IRIS and V1shingles, associated with a combined 
paralysis of three oculomotor nerves in a 40 year 
old HIV patient at the University Hospital of 
Brazzaville. 
  
CASE REPORT  
 
A 40 years old patient was seen for a pain of the 
right side of the face evolving for nearly a week.
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He described the pain as burning electrical 
discharge encompassing the eye, the ear and the 
cheek. 
The review noted:  
 Bullous and necrotic lesions along the path of 
the right V1 (Figure 1); 
 Hutchinson's sign: presence of the above 
described lesions at the tip of the nose,  
 Right eyelid ptosis; 
 Complete ophthalmoplegia: right eye was 
fixed in the primary position regardless of the 
direction taken by the left eye (Fig. 2 and 3);  
  Anterior granulomatous uveitis; and 
 Intra ocular pressure (IOP): 25 mmHg. 
 The review of the left eye was normal (IOP = 
12 mmHg).  
The HIV serology was positive with a CD4 cell 
count equal to 150 / mm
3
. An ART had been 
introduced (Lamivudine, Zidovudine, and 
Nevirapine).The treatment of uveitis was as follow:  
 Valaciclovir oral route 1000 mg: three time a 
day one week;  
 Acetazolamide oral route 250mg twice a day 
one week;  
 Atropine 1% eye drops twice a day two weeks; 
Corticosteroids eye drops in decreasing doses 
were introduced one week after the   beginning of 
treatment for a month. For the balance of blood 





Figure 1: right III nerve paralysis (eyelid ptosis) 





Figure 2: paralysis of rights III, IV nerves and 




Figure 3: right VI nerve paralysis and right V1 
shingles in HIV patient 
 
The evolution was favorable in the first month, 
marked by the disappearance of pain, healing of 
skin lesions and normalization of IOP. For no 
apparent reason, the situation completely changed 
at the beginning of the second month. The 
installation of a non-granulomatous pan uveitis that 
had evolved rapidly in three weeks in a state of 
blindness due to a phtisis bulbi.  
The rapid improvement of CD4 count 
excluded the hypothesis of ART failure. The 






The goal of antiretroviral (ARV) therapy in 
HIV/AIDS is immune reconstitution. However, an 
aberrant manifestation of this effect sometimes 
occurs. IRIS also known as immune restoration 
disease. This syndrome is usually accompanied by 
an increase in CD4 cell count and/or a rapid 
decrease in viral load. Although most cases of IRIS 
occur in patients who have low CD4 counts and 
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high viral load levels when ARV therapy is 
initiated, IRIS can occur at any CD4 count (4, 5). 
The time of presentation is usually within the first 
four to eight weeks after initiation of ARV therapy. 
However, IRIS occurred many weeks after this 
initiation (3, 4). After immune reconstitution, 
inflammatory reactions to many pathogens have 
been described, including mycobacterium, fungi, 
virus and bacteria. IRIS that involves worsening of 
some malignancies, including Kaposi’s sarcoma 
and autoimmune phenomena have also been 
documented (6). Epidemiologic data regarding 
IRIS are variable and depend largely on the 
incidence and types of infections that patients have 
at the time of initiation of ARV therapy. The 
pathogenesis of IRIS is largely speculative. 
Although one common aspect of IRIS cases is a 
significant increase in CD4 cells after initiation of 
ARV therapy in patients who has low CD4 cells 
prior to treatment. The pathogenesis of the 
inflammatory response may not be the CD4 cell 
increase. Patients who develop IRIS may have 
preexisting perturbations in their T-regulatory cell 
profile. The proinflammatory and regulatory 
responses, such as cytokine imbalances, may 
significantly contribute to onset of this syndrome, 
particulary when ARV treatment is very active 
against HIV (4). IRIS may also be more severe in 
patients with a higher burden of organism, which 
also suggests that antigen load may play a role (6, 
7). 
IRIS symptoms range from mild to severe. 
The presentation of IRIS varies depending on the 
underlying opportunistic infections or illness. The 
spectrum of signs and symptoms of IRIS often 
poses a challenge to diagnosis. The etiologic 
diagnosis of IRIS is based on clinical judgment, 
and multiple diagnoses can be present. The 
somewhat characteristic presentations of many 
opportunistc infections may aid in the diagnosis of 
IRIS. In case of VZV infection, it may act VZV 
reactivation after initiation of ARV therapy or a 
worsening of symptoms (3-7). Prevention of 
complications associated with IRIS involves careful 
monitoring, particularly in patients with low CD4 
counts and a past or current history of co-
infections. After initiating ARV therapy, clinicians 
should be alert to the possibility of IRIS as CD4 cell 
counts are restored. Clinicians should initiate 
symptomatic treatment and supportive care for 
patients with IRIS. In severe cases, clinicians 
should consider prescribing prednisone 1-2 mg/kg 
or equivalent for one to two weeks. Except in 
severe cases, ARV therapy should not be 
interrupted in patients with IRIS (7). In connection 
with multiple oculomotor nerves damage in young 
subjects, two other differential diagnoses can be 
mentioned: multiple sclerosis and Tolosa-Hunt’s 
syndrome. The Tolosa-Hunt’s syndrome is 
characterized by retroorbital pain and in the V1 
territory, sometimes associated with an apex 
syndrome without change of CD4 cell count (8). 
Multiple Sclerosis is characterized by chronic 
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